तुलना करने के लिए मीट्रिक्स | MTLF | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधMTLFपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −2.8x | −1.4x | −0.3x | |
PEG अनुपात | 0.05 | 0.00 | 0.00 | |
क़ीमत/बुक | 7.6x | 0.7x | 2.6x | |
क़ीमत / एलटीएम बिक्री | - | 3.2x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 1,601.6% | 50.4% | |
उचित मूल्य अपसाइड | अनलॉक करें | 20.4% | 6.4% | अनलॉक करें |
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury; and CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications. The company was incorporated in 2019 and is based in Ness Ziona, Israel.